Suppr超能文献

左心室舒张功能障碍对肺动脉高压患者肺移植结局的影响。

Impact of Left Ventricular Diastolic Dysfunction on Lung Transplantation Outcome in Patients With Pulmonary Arterial Hypertension.

机构信息

Pulmonology Institute, Department of Medicine, Soroka Medical Center, Faculty of Health Sciences Ben-Gurion University, Beer-Sheva, Israel.

Meir Medical Center, Faculty of Health Sciences, Tel- Aviv University, Tel-Aviv, Israel.

出版信息

Am J Transplant. 2017 Oct;17(10):2705-2711. doi: 10.1111/ajt.14352. Epub 2017 Jul 3.

Abstract

Diastolic dysfunction may influence perioperative outcome, early graft function, and long-term survival. We compared the outcomes of double lung transplantation (DLTx) for patients with pulmonary arterial hypertension (PAH) with preoperative left ventricular (LV) diastolic dysfunction with the outcomes of patients without diastolic dysfunction. Of 116 consecutive patients with PAH (who underwent transplantation between January 1995 and December 2013), 44 met our inclusion and exclusion criteria. Fourteen (31.8%) patients with diastolic dysfunction pretransplantation had a higher body mass index (29 [IQR 21.5-32.6] vs 22.4 [IQR 19.9-25.3] kg/m ) and mean pulmonary arterial pressure (54.6 ± 10 mmHg vs 47 ± 11.3 mmHg) and right atrial pressure (16.5 ± 5.2 mmHg vs 10.6 ± 5.2 mmHg). The patients received extracorporeal life support more frequently (33% vs 7% [p = 0.02]), had worse APACHE II scores (21.7 ± 7.4 vs 15.3 ± 5.3 [p = 0.02]), and a trend toward worse ventilator-free days (2.5 [IQR 6.5-32.5] vs 17 [IQR 3-23] [p = 0.08]). There was no effect on development of primary graft dysfunction or intensive care unit/hospital survival. One-year survival was worse (hazard ratio [HR] 4.45, 95% confidence interval [CI] 1.3-22, p = 0.02). Diastolic dysfunction was the only variable that correlated with overall survival (HR 5.4, 95% CI 1.3-22, p = 0.02). Diastolic dysfunction leads to early postoperative morbidity and worse survival in patients with PAH after DLTx.

摘要

舒张功能障碍可能影响围手术期结局、早期移植物功能和长期生存率。我们比较了术前左心室(LV)舒张功能障碍的肺动脉高压(PAH)患者与无舒张功能障碍患者的双肺移植(DLTx)结局。在 1995 年 1 月至 2013 年 12 月期间连续接受肺动脉高压(PAH)治疗的 116 例患者中,有 44 例符合我们的纳入和排除标准。14 例(31.8%)术前舒张功能障碍的患者体质量指数(29 [IQR 21.5-32.6] vs 22.4 [IQR 19.9-25.3] kg/m2)和平均肺动脉压(54.6 ± 10mmHg vs 47 ± 11.3mmHg)和右心房压(16.5 ± 5.2mmHg vs 10.6 ± 5.2mmHg)更高。这些患者更频繁地接受体外生命支持(33% vs 7% [p=0.02]),APACHE II 评分更高(21.7 ± 7.4 vs 15.3 ± 5.3 [p=0.02]),且呼吸机无依赖天数的趋势更差(2.5 [IQR 6.5-32.5] vs 17 [IQR 3-23] [p=0.08])。原发移植物功能障碍或重症监护病房/医院生存率无影响。1 年生存率更差(危险比[HR] 4.45,95%置信区间[CI] 1.3-22,p=0.02)。舒张功能障碍是唯一与总生存相关的变量(HR 5.4,95%CI 1.3-22,p=0.02)。舒张功能障碍导致肺动脉高压患者接受双肺移植后早期术后发病率和生存率下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验